Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

64Cu-DOTA-trastuzumab

Known as: Copper Cu 64-DOTA-Trastuzumab 
A radioimmunoconjugate containing the recombinant humanized monoclonal antibody trastuzumab conjugated with the bifunctional, macrocyclic chelating… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
e12525Background: Having demonstrated that 64Cu-DOTA trastuzumab is an effective PET imaging agent for HER2 positive (HER2… 
2016
2016
Background: It is estimated that 10-30% of all breast cancer patients at some point develop brain metastases. Overexpression of… 
Highly Cited
2013
Highly Cited
2013
A bifunctional derivative of the versatile acyclic chelator H4octapa, p-SCN-Bn-H4octapa, has been synthesized for the first time… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
2010
2010
Non‐small cell lung carcinomas (NSCLC) overexpress the Her2/neu gene in approximately 59% of cases. Trastuzumab, a humanized… 
2010
2010
In this study, we labeled trastuzumab with (177)Lu to synthesize a new radiopharmaceutical for therapy of breast cancer and at… 
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
Purpose17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat-shock protein 90 (Hsp90) inhibitor, has been… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5